Compared with MET-TKIs and neutralizing antibodies targeting MET activation, MET-CAR-T cells recognize and kill HCC cells based on total MET expression, and the activity is independent of MET signaling pathway activity. This evidence concerns the gene MET and hepatocellular carcinoma.